James Delorme, PhD, is a licensing manager in Memorial Sloan Kettering Cancer Center’s Office of Technology Development (OTD). He is a member of OTD’s Technology Management and Commercialization Unit.
Prior to joining MSK in 2021, James was a biotechnology equity research associate, first at Piper Sandler and then at Cowen. He earlier served as a technology transfer fellow at the University of Michigan.
James holds a PhD in Neuroscience from the University of Michigan; a Master’s of Science in Developmental and Neurobiology from the Université de Fribourg in Switzerland; and a Bachelor’s of Science in Neuroscience from the University of Delaware.